Showing results (1291-1300 of 1,717) with videos related to
Sort By:
Pageof 172
Blood|December 14, 2016
Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemiaJason A Powell, Alexander C Lewis, Wenying Zhu, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 24, 2016
[Cytogentic and prognostic characteristic of acute myeloid leukemia with monosomal karyotype]Z Li, H Wei, D Lin, et al.Blood|September 1, 2021
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLLPiers Blombery, Thomas E Lew, Michael A Dengler, et al.JNCI Cancer Spectrum|May 24, 2019
Contemporary Validation of a Nomogram Predicting Colon Cancer Recurrence, Revealing All-Stage Improved OutcomesTsuyoshi Konishi, Yoshifumi Shimada, Meier Hsu, et al.British Journal of Cancer|February 8, 2014
EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivoJ-H Wei, J-Z Cao, D Zhang, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 14, 2020
[Rituximab combined with short-course and intensive regimen for Burkitt leukemia: efficacy and safety analysis]Y Li, X Y Gong, X L Zhao, et al.Journal of Geophysical Research. Space Physics|April 19, 2021
Determining EMIC Wave Vector Properties Through Multi-Point Measurements: The Wave Curl AnalysisS K Vines, B J Anderson, R C Allen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2019
Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II StudyAndrew H Wei, Stephen A Strickland, Jing-Zhou Hou, et al.Cancer Medicine|August 24, 2021
Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysisStéphane de Botton, Joseph M Brandwein, Andrew H Wei, et al.Blood Advances|December 15, 2022
Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cellsCharis E Teh, Hongke Peng, Meng-Xiao Luo, et al.Pageof 172